INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.

$7.32  -0.06 (-0.81%)
As of 12/03/2021 10:06:06 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Israel
Country of incorporation:  
IPO date:  07/25/2017
Outstanding shares:  42,671,380
Average volume:  141,583
Market cap:   $314,914,784
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   18.62
PB ratio:   0.71
PS ratio:   1.88
Return on equity:   3.81%
Net income %:   9.81%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy